Endometrial cancer: Prognostic significance of risk classification based on pre-intraoperative findings

Archives of Gynecology and Obstetrics

Volumn 285, Issue 2, 2012, Pages 521-527

  Maneschi, Francesco ^a   Ceccacci, Irene ^a   Perugini, Angela ^a   Pane, Cristina ^a   Simeone, Alessia ^a   Manicone, Annamaria ^a  

^a SANTA MARIA GORETTI HOSPITAL   (Italy)

Author keywords

Endometrial cancer; Pre intraoperative evaluation; Prognosis; Risk assessment

Indexed keywords

PACLITAXEL; PLATINUM;

ACCURACY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; METASTASIS; PATIENT; PATIENT CODING; PRE INTRAOPERATIVE RISK CLASSIFICATION; PREDICTION; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURGEON;

ABDOMINAL NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIECTOMY; PACLITAXEL; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS; SALPINGECTOMY;

EID: 84864430369     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2004-9     Document Type: Article

References (35)

1. Creasman WT, Odicino F, Maisonneuve P et al (2006) Carcinoma of the corpus uteri. Int J Gynecol Obst 95:S105-S143
2. Mariani A, Webb MJ, Keeney GL et al (2000) Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182:1506-1519
3. Creasman WT, Morrow CP, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study. Cancer 60S:2035-2041
4. Morrow CP, Bundy BN, Kurman R et al (1991) Relationship between surgical-pathological risk factors and outcome in clinical stages I and II carcinoma of the endometrium. Gynecol Oncol 40:55-65
5. Mariani A, Keeney GL, Aletti G (2004) Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 92:833-838
6. Mariani A, Webb MJ, Keeney GL (2003) Endometrial carcinoma: predictors of peritoneal failure. Gynecol Oncol 89:236-242
7. Creutzberg CL, Van Putten WL, Koper PC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial PORTEC study group. Post operative radiation therapy in endo-metrial carcinoma. Lancet 355:1404-1411
8. Orr JW Jr, Holimon JL, Orr PF (1997) Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 176:777-788
9. Bristow RE, Zerbe MJ, Rosenshein NB et al (2000) Stage IVB Endometrial Carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol 78:85-91
10. Holland CM (2008) The role of radical surgery in Carcinoma of endometrium. Clinical Oncol 20:448-456
11. Hardesty L, Sumkin J, Nath M et al (2000) Use of preoperative MR imaging in the management of endometrial carcinoma: cost analysis. Radiology 215:45-49
12. Zerbe M, Bristow R, Grumbine F et al (2000) Inability of pre-operative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer. Gynecol Oncol 78:67-70
13. Traen K, Hølund B, Mogensen O (2007) Accuracy of preopera-tive tumor grade and intraoperative gross examination of myo-metrial invasion in patients with endometrial cancer. Acta Obstet Gynecol Scand 86:739-741
14. Frumovitz M, Singh DK, Meyer L et al (2004) Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 95:463-468
15. Franchi M, Ghezzi F, Melpignano M et al (2000) Clinical value of intraoperative gross examination in endometrial cancer. Gynecol Oncol 76:357-361
16. Egle D, Grissemann B, Zeimet AG et al (2008) Validation of intraoperative risk assessment on frozen section for surgical management of endometrial carcinoma. Gynecol Oncol 110:286-292
17. Celik C, Ozdemir S, Esen H et al (2010) The clinical value of preoperative and intraoperative assessments in the management of endometrial cancer. Int J Gynecol Cancer 20:358-362
18. Scully RE, Bonfiglio TA, Kurman RJ et al (1994) Histological typing of female genital tract tumours, 2nd edn. Springer, Berlin, pp 13-18
19. FIGO (1989) News: corpus cancer staging. Int J Gynecol Obstet 28:19-20
20. Maneschi F, Nardi S, Sarno M et al (2008) Endometrial carcinoma: intraoperative evaluation of myometrial invasion A prospective study. Minerva Ginecol 60:267-272
21. Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol 92:744-751
22. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
23. Leijon T, Rosenberg P, Boeryd B (1997) Total abdominal hysterectomy and bilateral salpingo-oophorectomy: a sufficient treatment for patients with low risk endometrial carcinoma. Int J Gynecol Cancer 7:376-380
24. Poulsen HK, Jacobsen M, Bertelsen K et al (1996) Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk cases. Int J Gynecol Cancer 6:38-43
25. Lim P, Aquino-Parsons CF, Wong F et al (1999) Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators. Gynecol Oncol 73:191-195
26. Larson DM, Broste SK, Krawisz BR (1998) Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 91:355-359
27. Gal D, Recio FO, Zamurovic D (1991) Lymphovascular space involvement: a prognostic indicator in endometrial adenocarci-noma. Gynecol Oncol 42:142-145
28. Briët JM, Hollema H, Reesink N et al (2005) Lymphovascular space involvement: an independent prognostic factor in endo-metrial cancer. Gynecol Oncol 96:799-804
29. Mariani A, Sebo TJ, Katzmann JA et al (2005) Endometrial cancer: can nodal status be predicted with curettage? Gynecol Oncol 96:594-600
30. Benedetti Panici P, Basile S, Maneschi F et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707-1716
31. Petru E, Lück HJ, Stuart G et al (2009) Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol 143:69-74
32. Orton J, Blake B (2009) Adjuvant external beam radiotherapy (EBRT) in the treatment of endometrial cancer: results of the randomised MRC ASTEC and NCIC CTG EN5 trial. Lancet 373:137-146
33. Maggi R, Lissoni A, Spina F et al (2006) Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 95:266-271
34. Chan JK, Urban R, Cheung MK et al (2007) Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11, 443 patients. Cancer 109:2454-2460
35. Cutillo G, Cignini P, Visca P et al (2007) Endometrial biopsy by means of the hysteroscopic resectoscope for the evaluation of tumor differentiation in endometrial cancer: a pilot study. Eur J Surg Oncol 33:907-910